Respiratory
Respiratory
Boehringer Ingelheim
has over 90 years
of heritage
in managing
respiratory diseases
Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
New GOLD recommendations: Role of LABA/LAMA combinations in COPD
Document ID: PC-TH-100383
01/03/2019
Author: Prof. Claus F. Vogelmeier
In the new GOLD guidelines, GOLD D patients should be initiated on LAMA/LABA therapy. Only patients who experience further exacerbations on LAMA/LABA therapy should be considered for treatment escalation with addition of an ICS.
Related content
PC-TH-100292
Production date: Mar 2019
Production date: Mar 2019